Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development

Humana Press

Published by Humana Press, 2010
ISBN 10: 1617376124 / ISBN 13: 9781617376122
Used / Paperback / Quantity Available: 0
Available From More Booksellers
View all  copies of this book

About the Book

We're sorry; this specific copy is no longer available. AbeBooks has millions of books. We've listed similar copies below.

Description:

We ship International with Tracking Number! May not contain Access Codes or Supplements. Buy with confidence, excellent customer service! L. Bookseller Inventory #

About this title:

Book ratings provided by Goodreads:
0 avg rating
(0 ratings)

Synopsis: It is generally easy to define the efficacy of a new the- peutic agent. However, what is even more difficult and more challenging yet more important is to define its safety when administered to millions of patients with multi-faceted d- eases, co-morbidities, sensitivities and concomitant medi- tions. The commonest cause of new drug discontinuations, cause for disapproval from marketing and removal from the market after approval is a drug s effect on cardiac repolari- tion which is essentially identified by increasing the duration of the QTc interval duration on the standard 12-lead elect- cardiogram (ECG). Cardiac Safety of Noncardiac Drugs: Practical Guide- Joel Morganroth, MD lines for Clinical Research and Drug Development is designed to present the current preclinical, clinical, and re- latory principles to assess the cardiac safety of new drugs based primarily on their effects on the ECG. Practical gu- ance to define cardiac safety at all stages of clinical research and drug development are featured and discussed by inter- tionally recognized experts with academic, industrial, and regulatory experience. Each chapter contains the best ava- able evidence, the author s personal opinions, areas of c- troversy, and future trends. Although some of the areas are highly specialized, this book has been designed for a broad audience ranging from medical and graduate students to cli- cal nurses, clinical trial coordinators, safety officers, data managers, statisticians, regulatory authorities, clinicians, and Ihor Gussak, MD, PhD scientists."

From the Back Cover: Although it is relatively easy to determine the efficacy of a new drug, it is difficult to establish its safety when administered to millions of patients with multifaceted diseases, co-morbidities, sensitivities, and multiple drug use. In Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development, basic and clinical researchers from industry and academia detail the preclinical, clinical, and regulatory principles currently used to assess the cardiac safety of new drugs from their effects on the electrocardiogram (ECG). The authors explain the parameters of cardiac safety at all stages of clinical research and drug development, including both the preclinical and pharmacogenomic aspects generally and the clinical methodologies and technical aspects for investigational drugs based on cardiac repolarization, as defined by the duration of the QTc interval. Additional chapters comprehensively review the application of electrocardiology in clinical research, demonstrating the fundamentals of ECG interpretation in clinical trials, the statistical analysis plans for ECG data obtained in formal clinical trials, and the practical interpretation of the results. Highlights include practical guidance on how to conduct a thorough ECG Trial in New Drug Development, how to use new ECG and web-based technology in clinical research, and how to follow the new FDA requirements for ECG submissions.
Authoritative and up-to-date, Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development offers clinical researchers in industry and academia expert practical advice on establishing their product's cardiac safety, predicting regulatory actions, and getting it successfully to market.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Cardiac Safety of Noncardiac Drugs: ...
Publisher: Humana Press
Publication Date: 2010
Binding: Paperback
Book Condition: Used: Good

Top Search Results from the AbeBooks Marketplace

1.

JOEL MORGANROTH
Published by Humana Press (2010)
ISBN 10: 1617376124 ISBN 13: 9781617376122
New Paperback Quantity Available: 1
Seller
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Humana Press, 2010. Paperback. Book Condition: NEW. 9781617376122 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE0309038

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 248.67
Convert Currency

Add to Basket

Shipping: US$ 10.30
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

Published by Humana Press Inc., United States (2010)
ISBN 10: 1617376124 ISBN 13: 9781617376122
New Paperback Quantity Available: 10
Seller
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2010. Paperback. Book Condition: New. 1st ed. Softcover of orig. ed. 2005. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. It is generally easy to define the efficacy of a new the- peutic agent. However, what is even more difficult and more challenging yet more important is to define its safety when administered to millions of patients with multi-faceted d- eases, co-morbidities, sensitivities and concomitant medi- tions. The commonest cause of new drug discontinuations, cause for disapproval from marketing and removal from the market after approval is a drug s effect on cardiac repolari- tion which is essentially identified by increasing the duration of the QTc interval duration on the standard 12-lead elect- cardiogram (ECG). Cardiac Safety of Noncardiac Drugs: Practical Guide- Joel Morganroth, MD lines for Clinical Research and Drug Development is designed to present the current preclinical, clinical, and re- latory principles to assess the cardiac safety of new drugs based primarily on their effects on the ECG. Practical gu- ance to define cardiac safety at all stages of clinical research and drug development are featured and discussed by inter- tionally recognized experts with academic, industrial, and regulatory experience.Each chapter contains the best ava- able evidence, the author s personal opinions, areas of c- troversy, and future trends. Although some of the areas are highly specialized, this book has been designed for a broad audience ranging from medical and graduate students to cli- cal nurses, clinical trial coordinators, safety officers, data managers, statisticians, regulatory authorities, clinicians, and Ihor Gussak, MD, PhD scientists. Bookseller Inventory # LIE9781617376122

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 253.63
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Published by Humana Press (2010)
ISBN 10: 1617376124 ISBN 13: 9781617376122
New Softcover Quantity Available: 15
Print on Demand
Seller
Rating
[?]

Book Description Humana Press, 2010. Book Condition: New. This item is printed on demand for shipment within 3 working days. Bookseller Inventory # LP9781617376122

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 304.71
Convert Currency

Add to Basket

Shipping: US$ 3.52
From Germany to U.S.A.
Destination, Rates & Speeds

4.

Joel Morganroth (Editor), Ihor Gussak (Editor)
Published by Humana Press (2010)
ISBN 10: 1617376124 ISBN 13: 9781617376122
New Paperback Quantity Available: 1
Seller
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Humana Press, 2010. Paperback. Book Condition: New. Softcover reprint of hardcover 1. Bookseller Inventory # DADAX1617376124

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 343.74
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

5.

Published by Humana Press (2010)
ISBN 10: 1617376124 ISBN 13: 9781617376122
New Paperback Quantity Available: 1
Print on Demand
Seller
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Humana Press, 2010. Paperback. Book Condition: Brand New. reprint edition. 372 pages. 10.00x7.01x0.89 inches. This item is printed on demand. Bookseller Inventory # zk1617376124

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 387.02
Convert Currency

Add to Basket

Shipping: US$ 7.72
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Published by Humana Press (2010)
ISBN 10: 1617376124 ISBN 13: 9781617376122
New Paperback Quantity Available: 1
Seller
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Humana Press, 2010. Paperback. Book Condition: New. book. Bookseller Inventory # M1617376124

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 408.10
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds